Skip to main content

Gritstone bio, Inc. (GRTS)

NASDAQ: GRTS · IEX Real-Time Price · USD
11.58 -0.63 (-5.16%)
Dec 3, 2021 4:00 PM EST - Market closed

Total Valuation

Gritstone bio has a market cap or net worth of $787.30 million. The enterprise value is $598.24 million.

Market Cap787.30M
Enterprise Value598.24M

Important Dates

The latest earnings date was Thursday, November 4, 2021 before market open.

Last Earnings DateNov 4, 2021
Ex-Dividend Daten/a

Share Statistics

Gritstone bio has 67.99 million shares outstanding. The number of shares has increased by 106.03% in one year.

Shares Outstanding67.99M
Shares Change (YoY)+106.03%
Shares Change (QoQ)+1.34%
Owned by Insiders (%)3.38%
Owned by Institutions (%)62.90%

Valuation Ratios

PE Ration/a
Forward PEn/a
PS Ratio16.93
PB Ratio3.79
P/FCF Ration/a
PEG Ration/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is n/a, with a EV/FCF ratio of n/a.

EV / Earningsn/a
EV / Sales12.87
EV / EBITn/a
EV / FCFn/a

Financial Position

The company has a current ratio of 6.01, with a Debt / Equity ratio of 0.13.

Current Ratio6.01
Quick Ratio5.96
Debt / Equity0.13
Debt / EBITDA-0.47
Debt / FCF-0.48

Financial Efficiency

Return on Equity (ROE)-38.50%
Return on Assets (ROA)-30.10%
Return on Capital (ROIC)-62.50%
Revenue Per Employee$247,335
Profits Per Employee-$385,532
Employee Count188
Asset Turnover0.19
Inventory Turnovern/a


Income Taxn/a
Effective Tax Raten/a

Stock Price Statistics

The stock price has increased by +284.35% in the last 52 weeks. The beta is 0.06, so Gritstone bio's price volatility has been lower than the market average.

Beta (1Y)0.06
52-Week Price Change+284.35%
50-Day Moving Average10.71
200-Day Moving Average9.61
Average Volume (30 Days)1,238,458

Short Selling Information

Short Interest1.76M
Short % of Shares Out2.58%
Short % of Float3.89%
Short Ratio (days to cover)1.76

Income Statement

In the last 12 months, Gritstone bio had revenue of $46.50 million and -$72.48 million in losses. Earnings per share was -$1.07.

Gross Profit46.50M
Operating Income-72.57M
Net Income-72.48M
Earnings Per Share (EPS)-$1.07
Full Income Statement

Balance Sheet

The company has $216.36 million in cash and $27.30 million in debt, giving a net cash position of $189.06 million or $2.78 per share.

Cash & Cash Equivalents216.36M
Total Debt27.30M
Net Cash189.06M
Net Cash Per Share$2.78
Book Value207.96M
Book Value Per Share3.06
Working Capital182.09M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$52.12 million and capital expenditures -$4.41 million, giving a free cash flow of -$56.52 million.

Operating Cash Flow-52.12M
Capital Expenditures-4.41M
Free Cash Flow-56.52M
FCF Per Share-$0.83
Full Cash Flow Statement


Gross margin is 100.00%, with operating and profit margins of -156.07% and -155.87%.

Gross Margin100.00%
Operating Margin-156.07%
Pretax Marginn/a
Profit Margin-155.87%
EBITDA Margin-125.53%
EBIT Margin-155.87%
FCF Margin-121.55%

Dividends & Yields

Gritstone bio does not appear to pay any dividends at this time.

Dividend Per Sharen/a
Dividend Yieldn/a
Earnings Yield-9.21%
FCF Yield-7.18%
Dividend Growth (YoY)n/a
Payout Ration/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Daten/a
Split Typen/a
Split Ration/a